Nestle is looking to turn the rapid growth of GLP-1 weight-loss drugs into a new business opportunity by developing products specifically for people taking medicines such as Ozempic and Wegovy. The company is using artificial intelligence and nutritional science to study the effects of rapid weight loss and identify products that could support users’ nutritional […]
